- $31.85bn
- $36.75bn
- $5.68bn
- 99
- 14
- 69
- 64
Annual income statement for Equifax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,128 | 4,924 | 5,122 | 5,265 | 5,681 |
| Cost of Revenue | |||||
| Gross Profit | 2,390 | 2,943 | 2,945 | 2,930 | 3,162 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,451 | 3,786 | 4,066 | 4,332 | 4,639 |
| Operating Profit | 677 | 1,138 | 1,056 | 934 | 1,042 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 685 | 949 | 930 | 718 | 811 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 526 | 749 | 700 | 552 | 607 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 520 | 744 | 696 | 545 | 604 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 520 | 744 | 696 | 545 | 604 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.43 | 6.08 | 5.79 | 4.63 | 5.12 |
| Dividends per Share |